Anastasios (Tassos) Lymperopoulos, BPharm, MSc, PhD, FAHA
Assistant Professor of Pharmacology
Department of Pharmaceutical Sciences
College of Pharmacy
Nova Southeastern University
3200 S. University Dr
Health Professions Division (Terry)
Fort Lauderdale, FL 33328, USA
Dr. Lymperopoulos’s career started by earning MSc in Medicinal Chemistry followed by PhD in Pharmacology, after graduating from the School of Pharmacy of the University of Patras, Greece. Its major turning point was in 2004, when he joined the lab of Dr. Walter Koch, a former postdoctoral fellow of Nobel laureate Professor Robert Lefkowitzs lab at Duke University. In addition, he has been a post-doctoral research fellow of the AHA for a total of three years in the past, and, in fact, his postdoctoral fellowship application with AHA in 2007 got an unusual 1-year extension based on its exceptionally high score. He has also been a finalist for the AHA-sponsored Melvin L. He holds two (provisional) research patents, and as a research grant reviewer for AHA. In addition, he is elected Fellow of the American Heart Association (FAHA) and its Council on Basic Cardiovascular Sciences (BCVS).
His research interests include: Molecular pharmacology, Physiology and Biology of G protein-coupled (heptahelical or seven transmembrane-spanning) receptors, Heart Failure, Cardiovascular Disease, Neurohormonal control of the Circulation, Adrenal Physiology and Pharmacology, Receptors for Adrenaline and Noradrenaline, Catecholamines, Receptors for Angiotensin II, Signal Transduction, Gene Therapy, Transgenic mice and rats, Aldosterone production regulation, Regulation of Adrenergic and Angiotensin Receptors, G protein-coupled receptor Kinases, Beta-Arrestins, Novel Biased G protein-Coupled Receptor Ligands.
• Lead-author publication in Nature Medicine
• 4-year Scientist Development Grant award by the American Heart Association (AHA)
Marcus Young Investigator Award in Basic Cardiovascular Sciences
• Cardiovascular Research Award of the Council on Basic Cardiovascular Sciences of the European Society of Cardiology (ESC)
He is currently serving on the Editorial Boards of two peer-reviewed journals, as a regular peer-reviewer for several prestigious journals, including British Journal of Pharmacology, Circulation Research, and American Journal of Cardiology.
He has published in various prestigious scientific journals, in addition to Nature Medicine, such as: Circulation, JACC, PNAS, JBC, and Molecular Pharmacology.